• No results found

Carbidopa and Entacapone

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo<sup>&reg;</sup>)

... and entacapone), although the former produces a more positive effect on quality of life than the ...levodopa, carbidopa, and entacapone, used as initial levodopa therapy, significantly delays the ...

8

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson&rsquo;s disease

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson&rsquo;s disease

... combines carbidopa, levodopa, and enta- capone in one tablet should have similar pharmacokinetic and efficacy ...and entacapone taken separately and combined in one ...and entacapone) after an ...

10

Compatibility and stability studies of levadopa, carbidopa, entacapone and natural bioenhancer mixture

Compatibility and stability studies of levadopa, carbidopa, entacapone and natural bioenhancer mixture

... Levodopa, Carbidopa and Entacapone at room temperature (15°C to 30°C) 13 ...Levodopa, Carbidopa, Entacapone and Piperine physical mixture ...

8

A VALIDATED RP HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LEVODOPA, CARBIDOPA AND ENTACAPONE IN TABLET DOSAGE FORMS

A VALIDATED RP HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LEVODOPA, CARBIDOPA AND ENTACAPONE IN TABLET DOSAGE FORMS

... Levodopa, Carbidopa and Entacapone is simple, selective, rapid and ...Levodopa, Carbidopa and Entacapone in bulk and pharmaceutical dosage ...

16

Levodopa/carbidopa and entacapone in the treatment of Parkinson&rsquo;s disease: efficacy, safety and patient preference

Levodopa/carbidopa and entacapone in the treatment of Parkinson&rsquo;s disease: efficacy, safety and patient preference

... with carbidopa (CD) and the catechol-O-methyltransferase (COMT) inhibitor entacapone (EN) may reduce the onset of these motor complications to a certain ...levodopa, entacapone, Parkinson’s disease, ...

10

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

... and entacapone signifi cantly increases ON-time and affords greater functionality, as measured by the Unifi ed Parkinson’s Disease Rating Scale (UPDRS) with conventional ...and entacapone is generally well ...

10

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson&#39;s disease: systematic review, meta-analysis, and economic evaluation

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson&#39;s disease: systematic review, meta-analysis, and economic evaluation

... We searched PubMed, Embase, Cochrane Central Register of Controlled Trials, and three Chinese databases – WanFang Data, Chinese Science and Technology Journal Database, and China National Knowledge Infrastructure – from ...

11

HPLC METHOD FOR ESTIMATION OF DRUG RELEASE OF ENTACAPONE IN ENTACAPONE, LEVODOPA AND CARBIDOPA TABLETS

HPLC METHOD FOR ESTIMATION OF DRUG RELEASE OF ENTACAPONE IN ENTACAPONE, LEVODOPA AND CARBIDOPA TABLETS

... industry Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase ...When entacapone is given in conjunction with levodopa and carbidopa, plasma levels of levodopa are ...

10

HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DRUG RELEASE OF LEVODOPA AND CARBIDOPA IN ENTACAPONE, LEVODOPA AND CARBIDOPA TABLETS

HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DRUG RELEASE OF LEVODOPA AND CARBIDOPA IN ENTACAPONE, LEVODOPA AND CARBIDOPA TABLETS

... 2.1. Reagents and Materials: All analytical reagent grade (AR Grade) reagents were used for method development purpose. Acetonitrile (Merck) and tetrahydrofuran (Merck) were used for standard solution preparation. ...

11

STABILITY INDICATING METHOD OF CARBIDOPA AND LEVODOPA ASSAY IN CARBIDOPA, LEVODOPA AND ENTACAPONE FILM COATED TABLETS BY RP  HPLC

STABILITY INDICATING METHOD OF CARBIDOPA AND LEVODOPA ASSAY IN CARBIDOPA, LEVODOPA AND ENTACAPONE FILM COATED TABLETS BY RP HPLC

... of Carbidopa and levodopa was carried out using HPLC ...of carbidopa and levodopa in carbidopa, entacapone and levodopa film coated tablets by using ...between Carbidopa and 3-Methoxy ...

9

Increased dose of carbidopa with levodopa and entacapone improves “off” time in a randomized trial

Increased dose of carbidopa with levodopa and entacapone improves “off” time in a randomized trial

... by entacapone has translated into improved (placebo vs entacapone) daily “on/off ” times at 6 months by an average of ...increased carbidopa doses administered with levodopa and entacapone ...

11

Voltammetric Determination of Carbidopa Using a modified Multiwall Carbon Nanotube Paste Electrode

Voltammetric Determination of Carbidopa Using a modified Multiwall Carbon Nanotube Paste Electrode

... of carbidopa/levodopa carries the brand names of Sinemet, Parcopa and Atamet; while Stalevo is a combination with entacapone, which enhances the bioavailability of carbidopa and ...

10

Analytical Method Development and Validation of Entacapone Drug by Modern LC MS/MS Method to Quantify the Genotoxic Impurity

Analytical Method Development and Validation of Entacapone Drug by Modern LC MS/MS Method to Quantify the Genotoxic Impurity

... like carbidopa and levodopa. Entacapone is also used for the treatment of end-of-dose “wearing-off” in patients with parkinson’s disease in combination with carbidopa and ...compound. ...

8

Simultaneous estimation of levodopa and carbidopa in bulk, pharmaceutical dosage forms and dissolution sample analysis by RP HPLC PDA method

Simultaneous estimation of levodopa and carbidopa in bulk, pharmaceutical dosage forms and dissolution sample analysis by RP HPLC PDA method

... Literature survey revealed that few analytical methods like HPLC [3-9], LC-MS/MS [10], NMR [11], HPTLC [12], simultaneous UV spectrophotometric methods [13-15] and electrophoresis [16] have been reported for the ...

7

DETERMINATION OF ENTACAPONE IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC METHOD

DETERMINATION OF ENTACAPONE IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC METHOD

... inclusions. Entacapone is a nitrocatechol y known as 2-cyano-3(5- cyclohexa-1,5-di enyl)-N,N- enamide and belongs to the class of antiparkinson agents(ENT, ...Fig.1). Entacapone is a selec- tive and ...

7

Piggyback drug development: (Molecular docking of Entacapone analogues as direct M  tuberculosis InhA inhibitors)

Piggyback drug development: (Molecular docking of Entacapone analogues as direct M tuberculosis InhA inhibitors)

... from entacapone, a drug for Parkinson’s disease, which was also found to inhibit InhA ...for entacapone-like structures, which were then filtered based on LibDock ...of entacapone are potential ...

7

Dissolution Rate Enhancement of Entacapone and Formulation of its Oro- Dispersible Tablets: Applying Statistical Design

Dissolution Rate Enhancement of Entacapone and Formulation of its Oro- Dispersible Tablets: Applying Statistical Design

... The solubility and dissolution rate of entacapone can be enhanced by formulating its ICs with β­CD. Rapid dissolution of entacapone from the tablets formulated with PEG 4000 and crospovidone was seen. ...

14

Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions

Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions

... Cognitive impairment is a frequent non-motorsymptom of Parkinson’s dis- ease (PD). In early disease stage, this takes the features of dysexecutive syn- drome, and is mostly dependent on derangement of frontostriatal ...

12

Design and evaluation of entacapone controlled release trilayer matrix tablets in the management of parkinson’s disease

Design and evaluation of entacapone controlled release trilayer matrix tablets in the management of parkinson’s disease

... delivery system should deliver drug at a rate dictated by the needs of the body over a specific period of time. Sustained release tablets are intended to take once or twice daily, when compared with conventional dosage ...

11

Surface adsorbed templates for directing the crystal growth of entacapone as monitored using process analytical techniques

Surface adsorbed templates for directing the crystal growth of entacapone as monitored using process analytical techniques

... ATR-UVvis spectroscopy was used for solubility determination since the technique enabled the measurement of solute concentration in-situ, in the presence of solid particles, without the need for filtration. Direct ...

30

Show all 44 documents...

Related subjects